vs
Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $4.8M, roughly 1.6× Scilex Holding Co). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -961.9%, a 954.4% gap on every dollar of revenue. On growth, Marygold Companies, Inc. posted the faster year-over-year revenue change (-4.5% vs -67.8%). Over the past eight quarters, Marygold Companies, Inc.'s revenue compounded faster (-1.5% CAGR vs -33.6%).
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
MGLD vs SCLX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.6M | $4.8M |
| Net Profit | $-576.0K | $-46.1M |
| Gross Margin | 74.0% | 45.5% |
| Operating Margin | -8.3% | -2317.8% |
| Net Margin | -7.5% | -961.9% |
| Revenue YoY | -4.5% | -67.8% |
| Net Profit YoY | 67.0% | -613.7% |
| EPS (diluted) | $-0.01 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.6M | $4.8M | ||
| Q3 25 | $7.0M | $10.6M | ||
| Q2 25 | $7.2M | $9.9M | ||
| Q1 25 | $7.0M | $5.0M | ||
| Q4 24 | $8.0M | $14.9M | ||
| Q3 24 | $7.9M | $14.4M | ||
| Q2 24 | $8.3M | $16.4M | ||
| Q1 24 | $7.9M | $10.9M |
| Q4 25 | $-576.0K | $-46.1M | ||
| Q3 25 | $-356.0K | $-257.8M | ||
| Q2 25 | $-1.5M | $-44.0M | ||
| Q1 25 | $-1.0M | $-26.1M | ||
| Q4 24 | $-1.7M | $-6.5M | ||
| Q3 24 | $-1.6M | $-4.4M | ||
| Q2 24 | $-1.9M | $-37.6M | ||
| Q1 24 | $-529.0K | $-24.4M |
| Q4 25 | 74.0% | 45.5% | ||
| Q3 25 | 77.0% | 68.5% | ||
| Q2 25 | 67.8% | 66.9% | ||
| Q1 25 | 75.0% | 72.3% | ||
| Q4 24 | 74.1% | 68.5% | ||
| Q3 24 | 73.1% | 73.9% | ||
| Q2 24 | 72.5% | 73.2% | ||
| Q1 24 | 70.5% | 64.7% |
| Q4 25 | -8.3% | -2317.8% | ||
| Q3 25 | -18.2% | -1766.2% | ||
| Q2 25 | -16.5% | -207.2% | ||
| Q1 25 | -21.4% | -557.5% | ||
| Q4 24 | -22.8% | -190.5% | ||
| Q3 24 | -27.4% | -138.0% | ||
| Q2 24 | -33.3% | -95.4% | ||
| Q1 24 | -18.7% | -179.0% |
| Q4 25 | -7.5% | -961.9% | ||
| Q3 25 | -5.1% | -2441.5% | ||
| Q2 25 | -20.4% | -445.1% | ||
| Q1 25 | -14.4% | -521.2% | ||
| Q4 24 | -21.8% | -43.4% | ||
| Q3 24 | -20.1% | -30.4% | ||
| Q2 24 | -22.5% | -229.6% | ||
| Q1 24 | -6.7% | -224.0% |
| Q4 25 | $-0.01 | $-4.63 | ||
| Q3 25 | $-0.01 | $-22.17 | ||
| Q2 25 | $-0.04 | $-7.42 | ||
| Q1 25 | $-0.02 | $-2.26 | ||
| Q4 24 | $-0.04 | $8.53 | ||
| Q3 24 | $-0.04 | $-0.58 | ||
| Q2 24 | $-0.05 | $-7.67 | ||
| Q1 24 | $-0.01 | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $5.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $22.7M | $-207.8M |
| Total Assets | $27.8M | $365.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $5.0M | ||
| Q3 25 | $12.5M | $878.0K | ||
| Q2 25 | $12.8M | $4.1M | ||
| Q1 25 | $15.6M | $5.8M | ||
| Q4 24 | $14.9M | $3.3M | ||
| Q3 24 | $17.5M | $77.0K | ||
| Q2 24 | $15.0M | $6.9M | ||
| Q1 24 | $16.1M | $1.8M |
| Q4 25 | $22.7M | $-207.8M | ||
| Q3 25 | $22.9M | $-176.9M | ||
| Q2 25 | $23.0M | $-249.0M | ||
| Q1 25 | $24.3M | $-211.5M | ||
| Q4 24 | $23.4M | $-192.6M | ||
| Q3 24 | $25.5M | $-211.3M | ||
| Q2 24 | $26.6M | $-214.7M | ||
| Q1 24 | $28.4M | $-189.8M |
| Q4 25 | $27.8M | $365.0M | ||
| Q3 25 | $28.4M | $275.9M | ||
| Q2 25 | $30.4M | $83.8M | ||
| Q1 25 | $33.5M | $79.0M | ||
| Q4 24 | $33.0M | $93.0M | ||
| Q3 24 | $35.9M | $100.4M | ||
| Q2 24 | $32.9M | $104.5M | ||
| Q1 24 | $33.7M | $91.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-908.0K | $-17.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-908.0K | $-17.5M | ||
| Q3 25 | $-533.0K | $8.2M | ||
| Q2 25 | $-3.3M | $7.0M | ||
| Q1 25 | $-1.2M | $6.0M | ||
| Q4 24 | $-770.0K | $2.5M | ||
| Q3 24 | $-893.0K | $5.1M | ||
| Q2 24 | $-1.9M | $2.3M | ||
| Q1 24 | $-658.0K | $9.4M |
| Q4 25 | — | — | ||
| Q3 25 | $-562.0K | — | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-776.0K | — | ||
| Q3 24 | $-940.0K | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -8.1% | — | ||
| Q2 25 | -46.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -9.7% | — | ||
| Q3 24 | -11.9% | — | ||
| Q2 24 | -23.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
SCLX
Segment breakdown not available.
